ResistanceBio

ResistanceBio was focused on addressing the critical challenge of drug resistance in cancer treatment. Their mission involved developing innovative solutions to overcome the mechanisms by which cancer cells evade the effects of chemotherapy and targeted therapies. By tackling drug resistance, ResistanceBio aimed to improve patient outcomes and extend survival rates in various cancer types. However, the company is now inactive.